| Matthew Moeller, MD | |
|
4100 Lake Dr Se, Suite 205, Grand Rapids, MI 49546-8292 | |
| (616) 267-7414 | |
| (616) 267-7137 |
| Full Name | Matthew Moeller |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 19 Years |
| Location | 4100 Lake Dr Se, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386763704 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 4301085784 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Spectrum Health | Grand rapids, MI | Hospital |
| Spectrum Health United Hospital | Greenville, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectrum Health Primary Care Partners | 4587568647 | 1585 |
News Archive
The University of Maryland Schools of Dentistry (UM SOD) and Medicine (UM SOM) jointly announced today that they have received a five-year $10.7 million grant award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to study the causes, prevention and treatment of sexually-transmitted diseases (STDs).
A propensity for activities in the evening rather than in the morning may offer clues to behavioral problems in early adolescence, according to psychologists who have found that kids who prefer evenings are more likely to exhibit antisocial behavior, rule-breaking, and attention problems.
As families return from summer travels and children head back to school, Emergency Medical Associates (EMA) is preparing for a potential resurgence in the swine flu virus (H1N1) this fall. By using business intelligence (BI) solutions from SAP AG (NYSE: SAP), EMA will continue to pinpoint the movement of swine flu and alert federal organizations such as the Centers for Disease Control and Prevention (CDC) as well as 21 different emergency medical departments to patterns of outbreak.
Medivation, Inc. and Astellas Pharma Inc. today announced that patient enrollment was completed on November 15, 2010 in the Phase 3 AFFIRM study of the investigational drug MDV3100, a novel, triple-acting oral androgen receptor antagonist, in patients with advanced prostate cancer who have previously been treated with chemotherapy. The companies also announced that clinical development of MDV3100 in Japan has commenced, with the initiation of patient dosing in a Phase 1-2 clinical study.
› Verified 7 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134144801 PECOS PAC ID: 0547178311 Enrollment ID: O20031105000139 |
News Archive
The University of Maryland Schools of Dentistry (UM SOD) and Medicine (UM SOM) jointly announced today that they have received a five-year $10.7 million grant award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to study the causes, prevention and treatment of sexually-transmitted diseases (STDs).
A propensity for activities in the evening rather than in the morning may offer clues to behavioral problems in early adolescence, according to psychologists who have found that kids who prefer evenings are more likely to exhibit antisocial behavior, rule-breaking, and attention problems.
As families return from summer travels and children head back to school, Emergency Medical Associates (EMA) is preparing for a potential resurgence in the swine flu virus (H1N1) this fall. By using business intelligence (BI) solutions from SAP AG (NYSE: SAP), EMA will continue to pinpoint the movement of swine flu and alert federal organizations such as the Centers for Disease Control and Prevention (CDC) as well as 21 different emergency medical departments to patterns of outbreak.
Medivation, Inc. and Astellas Pharma Inc. today announced that patient enrollment was completed on November 15, 2010 in the Phase 3 AFFIRM study of the investigational drug MDV3100, a novel, triple-acting oral androgen receptor antagonist, in patients with advanced prostate cancer who have previously been treated with chemotherapy. The companies also announced that clinical development of MDV3100 in Japan has commenced, with the initiation of patient dosing in a Phase 1-2 clinical study.
› Verified 7 days ago
| Entity Name | Spectrum Health Primary Care Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
The University of Maryland Schools of Dentistry (UM SOD) and Medicine (UM SOM) jointly announced today that they have received a five-year $10.7 million grant award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to study the causes, prevention and treatment of sexually-transmitted diseases (STDs).
A propensity for activities in the evening rather than in the morning may offer clues to behavioral problems in early adolescence, according to psychologists who have found that kids who prefer evenings are more likely to exhibit antisocial behavior, rule-breaking, and attention problems.
As families return from summer travels and children head back to school, Emergency Medical Associates (EMA) is preparing for a potential resurgence in the swine flu virus (H1N1) this fall. By using business intelligence (BI) solutions from SAP AG (NYSE: SAP), EMA will continue to pinpoint the movement of swine flu and alert federal organizations such as the Centers for Disease Control and Prevention (CDC) as well as 21 different emergency medical departments to patterns of outbreak.
Medivation, Inc. and Astellas Pharma Inc. today announced that patient enrollment was completed on November 15, 2010 in the Phase 3 AFFIRM study of the investigational drug MDV3100, a novel, triple-acting oral androgen receptor antagonist, in patients with advanced prostate cancer who have previously been treated with chemotherapy. The companies also announced that clinical development of MDV3100 in Japan has commenced, with the initiation of patient dosing in a Phase 1-2 clinical study.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Moeller, MD 100 Michigan St Ne, Mc 845, Grand Rapids, MI 49503-2560 Ph: () - | Matthew Moeller, MD 4100 Lake Dr Se, Suite 205, Grand Rapids, MI 49546-8292 Ph: (616) 267-7414 |
News Archive
The University of Maryland Schools of Dentistry (UM SOD) and Medicine (UM SOM) jointly announced today that they have received a five-year $10.7 million grant award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to study the causes, prevention and treatment of sexually-transmitted diseases (STDs).
A propensity for activities in the evening rather than in the morning may offer clues to behavioral problems in early adolescence, according to psychologists who have found that kids who prefer evenings are more likely to exhibit antisocial behavior, rule-breaking, and attention problems.
As families return from summer travels and children head back to school, Emergency Medical Associates (EMA) is preparing for a potential resurgence in the swine flu virus (H1N1) this fall. By using business intelligence (BI) solutions from SAP AG (NYSE: SAP), EMA will continue to pinpoint the movement of swine flu and alert federal organizations such as the Centers for Disease Control and Prevention (CDC) as well as 21 different emergency medical departments to patterns of outbreak.
Medivation, Inc. and Astellas Pharma Inc. today announced that patient enrollment was completed on November 15, 2010 in the Phase 3 AFFIRM study of the investigational drug MDV3100, a novel, triple-acting oral androgen receptor antagonist, in patients with advanced prostate cancer who have previously been treated with chemotherapy. The companies also announced that clinical development of MDV3100 in Japan has commenced, with the initiation of patient dosing in a Phase 1-2 clinical study.
› Verified 7 days ago
Maureen U Tan- Pedres, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 100 Michigan St Ne, Suite A721, Grand Rapids, MI 49503 Phone: 616-391-3139 Fax: 616-391-3044 | |
Jeffery Allen Woo, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1900 Wealthy St Se, Ste 150, Grand Rapids, MI 49506 Phone: 616-459-3158 Fax: 616-988-0071 | |
Robert W Selfe, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 221 Michigan St Ne, Suite 200, Grand Rapids, MI 49503 Phone: 616-267-8950 Fax: 616-267-8585 | |
Dr. Erin Megan Pettijohn, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 250 Cherry St Se Ste 2200, Grand Rapids, MI 49503 Phone: 616-685-5600 | |
Dr. Andrew Leo Sochacki, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5800 Foremost Dr Se Ste 200, Grand Rapids, MI 49546 Phone: 616-389-1800 | |
Stephanie F Williams, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 145 Michigan St Ne, Suite 5200, Grand Rapids, MI 49503 Phone: 616-486-5933 Fax: 616-486-6489 | |
Simin Beg, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 145 Michigan St Ne Ste 3410, Grand Rapids, MI 49503 Phone: 616-391-9945 |